Related references
Note: Only part of the references are listed.Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma
Jun Hou et al.
HUMAN PATHOLOGY (2014)
Genomic and molecular characterization of esophageal squamous cell carcinoma
De-Chen Lin et al.
NATURE GENETICS (2014)
Complex interactions between the components of the PI3K/AKT/mTOR pathway, and with components of MAPK, JAK/STAT and Notch-1 pathways, indicate their involvement in meningioma development
Elias A. El-Habr et al.
VIRCHOWS ARCHIV (2014)
PIK3CA Mutation Is Associated with a Favorable Prognosis among Patients with Curatively Resected Esophageal Squamous Cell Carcinoma
Hironobu Shigaki et al.
CLINICAL CANCER RESEARCH (2013)
Lapatinib, a dual inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2, potentiates the antitumor effects of cisplatin on esophageal carcinoma
X. F. Guo et al.
DISEASES OF THE ESOPHAGUS (2013)
Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO
Victoria E. Clark et al.
SCIENCE (2013)
Targeting the PI3K-AKT-mTOR signaling network in cancer
Khurum H. Khan et al.
CHINESE JOURNAL OF CANCER (2013)
A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma
Penelope Korkolopoulou et al.
BJU INTERNATIONAL (2012)
Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas
Penelope Korkolopoulou et al.
HISTOPATHOLOGY (2012)
pERK activation in esophageal carcinomas: Clinicopathological associations
K. E. Tasioudi et al.
PATHOLOGY RESEARCH AND PRACTICE (2012)
High-Throughput Genotyping in Metastatic Esophageal Squamous Cell Carcinoma Identifies Phosphoinositide-3-Kinase and BRAF Mutations
Chi Hoon Maeng et al.
PLOS ONE (2012)
Comparative Genomic Analysis of Esophageal Adenocarcinoma and Squamous Cell Carcinoma
Nishant Agrawal et al.
CANCER DISCOVERY (2012)
Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder
Chih-Hao Sun et al.
HISTOPATHOLOGY (2011)
Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer
Lingyun Wei et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Association between AKT/mTOR signalling pathway and malignancy grade of human gliomas
Xue-yuan Li et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
ERK Crosstalks with 4EBP1 to Activate Cyclin D1 Translation during Quinol-Thioether-Induced Tuberous Sclerosis Renal Cell Carcinoma
Jennifer D. Cohen et al.
TOXICOLOGICAL SCIENCES (2011)
Phosphorylated mTOR Expression is Associated with Poor Prognosis for Patients with Esophageal Squamous Cell Carcinoma
Kotaro Hirashima et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Expression Status and Prognostic Significance of Mammalian Target of Rapamycin Pathway Members in Urothelial Carcinoma of Urinary Bladder After Cystectomy
Luciana Schultz et al.
CANCER (2010)
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
Qing-Bai She et al.
CANCER CELL (2010)
Mammalian target of rapamycin Hitting the bull's-eye for neurological disorders
Zhao Zhong Chong et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Absence of oncogenic AKT1 E17K mutation in prostate, esophageal, laryngeal and urothelial carcinomas, hepatoblastomas, gastrointestinal stromal tumors and malignant meningiomas
Hyeon Seok Eom et al.
ACTA ONCOLOGICA (2009)
Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA, and AKT1
Julio C. Ricarte-Filho et al.
CANCER RESEARCH (2009)
Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma
Ichiro Akagi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
PIK3CA mutation status in Japanese esophageal squamous cell carcinoma
Ryota Mori et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Trends in oesophageal cancer incidence and mortality in Europe
Cristina Bosetti et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling
Markus J. Riemenschneider et al.
CANCER RESEARCH (2006)
Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus
WA Phillips et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer
Z Salehi et al.
CLINICAL BIOCHEMISTRY (2006)
Oncogenic PI3K and its role in cancer
Y Samuels et al.
CURRENT OPINION IN ONCOLOGY (2006)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
SY Sun et al.
CANCER RESEARCH (2005)
Phosphorylation of mammalian target of rapamycin (mTOR) at ser-2448 is mediated by p70S6 kinase
GG Chiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
LS Harrington et al.
JOURNAL OF CELL BIOLOGY (2004)
Regulation of Raf-Akt cross-talk
K Moelling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
